The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
On Jun. 15, 2020, the German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp,…
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
On Jun. 15, 2020, Eli Lilly announced that the first patient has been enrolled in a Phase 3…
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
On Jun. 15, 2020, SIGA Technologies announced the U.S. Department of Defense (DoD) increased research and development funding…
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
On Jun. 15, 2020, Cleveland Clinic researchers announced they had developed the worldï¾’s first risk prediction model for…
On Jun. 14, 2020, McKesson announced that it had expanded its existing partnership with the Centers for Disease…
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeï¾’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…
On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with…
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyï¾’s…
On Jun. 12, 2020, the FDA announced it had approved an expanded indication for Merck’s GARDASIL9 for the…
On Jun. 12, 2020, a tiny genetic mutation in the SARS coronavirus 2 variant circulating throughout Europe and…
On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…
On Jun. 12, 2020, Cue Health announced that it had received Emergency Use Authorization from the U.S. Food…
On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of…
On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…
On Jun. 11, 2020, scientists announced the development of a new test that can help identify people who…
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
On Jun. 11, 2020, the FDA approved Viela Bio’s Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment…